Maintaining Data Integrity Under Pandemic Conditions

Data integrity had already become a top priority for the clinical and life science (pharma, biopharma, med device) sectors before the outbreak of COVID-19. Data Integrity Guidelines New guidance had been issued by both the FDA and the UK’s MHRA [...]